Article Text

other Versions

PDF
Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers
  1. Stephen M Lagana1,
  2. Eric D Braunstein2,
  3. Carolina Arguelles-Grande2,
  4. Govind Bhagat1,
  5. Peter H R Green2,
  6. Benjamin Lebwohl2
  1. 1Department of Pathology and Cell Biology, Columbia University and New York Presbyterian Hospital, New York, New York, USA
  2. 2Department of Medicine, Celiac Disease Center, Columbia University Medical Center, New York, New York, USA
  1. Correspondence to Dr Stephen M Lagana, Department of Pathology and Cell Biology, Columbia University and New York Presbyterian Hospital, 630 W 168th St., VC15-202, New York, NY 10032, USA; Sml2179{at}cumc.columbia.edu

Abstract

Aims A severe syndrome characterised by life-threatening diarrhoea and severe sprue-like histology has been described in patients taking the angiotensin receptor blocker (ARB) olmesartan. It is unknown whether there are any histopathological changes in patients without severe diarrhoea exposed to this medication. It is also unknown whether other ARBs cause sprue-like histology.

Methods Retrospective cohort study of patients with abdominal pain undergoing upper gastrointestinal endoscopy with duodenal biopsy who were taking ARBs. Patients taking olmesartan (n=20) and a non-olmesartan ARB (n=20) were compared with age and sex-matched controls. Histological features (classic sprue-like and other inflammatory changes) were analysed.

Results No single histopathological finding was significantly more common in olmesartan-using patients than controls. However, 10 of 20 olmesartan patients had one or more sprue-like histological features compared with 4 of 20 age-matched and sex-matched controls not taking ARBs (p=0.10). Patients taking ARBs other than olmesartan were not more likely than controls to have one or more of these sprue-like histological features (9/20 vs. 12/20, p=0.34).

Conclusions There were no statistically significant differences between olmesartan users with abdominal pain and controls for any single histopathological abnormality. However, there were trends towards significance for individual abnormalities as well as for a composite outcome of sprue-like changes. This raises the possibility that there is a spectrum of histological changes associated with olmesartan use.

  • SMALL INTESTINE
  • INFLAMMATION
  • GUT PATHOLOGY
  • GASTROINTESTINAL DISEASE

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.